ADC Therapeutics SA
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-148.2M | $278.6M |
| FY2024 | — | $-202.6M | $250.9M |
| FY2025 | — | $-185.8M | $261.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-148.2M | $278.6M |
| FY2024 | — | $-202.6M | $250.9M |
| FY2025 | — | $-185.8M | $261.3M |